Canopy Growth (CGC) Retained Earnings (2017 - 2025)
Canopy Growth's (CGC) quarterly Retained Earnings came in at -$7.9 billion in Q4 2025, down 122724.84% year-on-year from N/an in Q4 2024, and down 77772.74% quarter-over-quarter from $10.2 million in Q3 2025.
Canopy Growth (CGC) Retained Earnings (2017 - 2025) Analysis & Trends
Canopy Growth has disclosed Retained Earnings across 9 years of filings, most recently posting -$7.9 billion for Q4 2025.
- Retained Earnings for Q4 2025 came in at -$7.9 billion, down 122724.84% year-over-year; the trailing twelve-month figure through Dec 2025 was -$7.9 billion (down 122724.84% YoY), and the FY2025 annual result was -$7.6 billion, up 0.65% from the prior year.
- Retained Earnings came in at -$7.9 billion for Q4 2025 at Canopy Growth, down from $10.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $10.2 million in Q3 2025 to a low of -$7.9 billion in Q4 2025.
- The 5-year median for Retained Earnings is -$2.3 billion (2021), against an average of -$3.5 billion.
- Across the five-year window, Retained Earnings sank 1243290.86% in 2023 and surged 186.68% in 2025, its largest moves.
- Canopy Growth's Retained Earnings stood at -$21.2 million in 2021, then sank by 31283.52% to -$6.7 billion in 2022, then declined by 13.01% to -$7.5 billion in 2023, then soared by 99.91% to -$6.4 million in 2024, then sank by 122724.84% to -$7.9 billion in 2025.
- The last three Retained Earnings figures came in at -$7.9 billion (Q4 2025), $10.2 million (Q3 2025), and $5.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | -7.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.91 Bn |
| Sep 30, 2025 | 10.19 Mn |
| Jun 30, 2025 | 5.23 Mn |
| Mar 31, 2025 | -7.62 Bn |
| Dec 31, 2024 | -6.44 Mn |
| Sep 30, 2024 | -11.75 Mn |
| Jun 30, 2024 | -15.75 Mn |
| Mar 31, 2024 | -7.67 Bn |
| Dec 31, 2023 | -7.52 Bn |
| Sep 30, 2023 | -7.47 Bn |
| Jun 30, 2023 | -6.33 Mn |
| Mar 31, 2023 | -7.15 Bn |
| Dec 31, 2022 | -6.65 Bn |
| Sep 30, 2022 | -6.73 Bn |
| Jun 30, 2022 | -6.64 Bn |
| Mar 31, 2022 | 575,527.57 |
| Dec 31, 2021 | -21.20 Mn |
| Sep 30, 2021 | -21.80 Mn |
| Jun 30, 2021 | -4.62 Bn |
| Mar 31, 2021 | -27.05 Mn |